Review
Use of intermediate acting muscle relaxants by infusion: the future
Affiliations
- PMID: 9099306
Item in Clipboard
Review
Use of intermediate acting muscle relaxants by infusion: the future
Acta Anaesthesiol Belg.
1997.
Abstract
The usefulness of newer intermediate-acting muscle relaxants rocuronium and cisatracurium when used by infusion has been reviewed briefly and their main features pointed out. Comparative features of atracurium, vecuronium and mivacurium have also been described. Both new agents may have advantages for use by infusion particularly for longer procedures, due to the lack of detectable metabolites with rocuronium and production of comparatively smaller amounts of metabolites with cisatracurium.
Similar articles
-
Recent advances in myorelaxant therapy.Paediatr Anaesth. 2001;11(5):523-31. doi: 10.1046/j.1460-9592.2001.00661.x. Paediatr Anaesth. 2001. PMID: 11696115 Review. No abstract available.
-
Muscle relaxants in paediatric day case surgery.Eur J Anaesthesiol Suppl. 2001;23:47-52. Eur J Anaesthesiol Suppl. 2001. PMID: 11766247
-
Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.Int J Clin Monit Comput. 1996 Nov;13(4):217-24. doi: 10.1023/a:1016956507342. Int J Clin Monit Comput. 1996. PMID: 9080242
-
Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.Anesthesiology. 2007 Aug;107(2):245-52. doi: 10.1097/01.anes.0000270721.27309.b3. Anesthesiology. 2007. PMID: 17667568 Clinical Trial.
-
Muscle relaxants: a clinical update.Acta Anaesthesiol Scand Suppl. 1996;109:165-7. Acta Anaesthesiol Scand Suppl. 1996. PMID: 8901994 Review.